Vera Therapeutics: Kidney Drug Pivot Looks Like A Long Shot (NASDAQ:VERA)
Vera has a second asset targeting the BK Virus in kidney transplant patients. Both assets are long shots but management is experienced. See more on VERA stock here.
Source: seekingalpha.com